Transglutaminase participates in UVB-induced cell death pathways in human corneal epithelial cells

Louis Tong1, Zhuo Chen, Cintia S De Paiva

  • 1Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas 77030, USA.

Abstract

Insights

Transglutaminase activity regulates corneal cell death from UVB exposure by influencing tumor necrosis factor (TNF) receptor clustering and caspase activation, key steps in apoptosis.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Ultraviolet B (UVB) radiation induces apoptosis in human corneal epithelial cells.
  • Tumor necrosis factor (TNF) receptors play a role in cellular stress responses and apoptosis.
  • Transglutaminases are enzymes involved in protein cross-linking and cellular processes.

Purpose of the Study:

  • To investigate the role of transglutaminase in UVB-induced apoptosis of human corneal epithelial cells.
  • To determine if transglutaminase regulates tumor necrosis factor receptor clustering and caspase activation following UVB exposure.

Main Methods:

  • Utilized a human corneal epithelial cell line exposed to UVB radiation.
  • Assessed cell viability and apoptosis using MTT, TUNEL, and caspase-3 assays.
  • Examined TNF receptor-I clustering via immunofluorescent staining and transglutaminase activity using fluorescein-cadaverine uptake; transglutaminase expression was modulated using siRNA and exogenous enzyme delivery.

Main Results:

  • UVB exposure increased transglutaminase activity, decreased cell viability, and elevated TUNEL staining.
  • UVB and TNF-alpha induced TNF receptor-I clustering, which was inhibited by a transglutaminase inhibitor.
  • UVB elevated activated caspase-3 levels, an effect suppressed by the transglutaminase inhibitor; exogenous transglutaminase enhanced caspase-3 activation.

Conclusions:

  • Transglutaminase enzymatic activity is integral to corneal epithelial cell death induced by UVB.
  • Transglutaminase appears to regulate UVB-induced apoptosis by modulating TNF receptor-I clustering and caspase-3 activation.

Related Concept Videos